MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    LRRK2 I1371V Mutation Induces ER Stress, Mitochondrial Dysfunction, and Impaired Mitophagy in Parkinson’s Disease Astrocytes

    R. Banerjee, V. Holla, N. Kamble, R. Yadav, P. Pal, I. Datta (Bangalore, India)

    Objective: This study examines the pathogenic effect of the LRRK2 I1371V mutation on mitochondrial dysfunction, as a result of ER calcium dysregulation, and impaired mitophagy…
  • 2025 International Congress

    Bassoon (BSN) Gene Mutations: A Missing Link in Gait and Balance Dysfunction Across Parkinsonian Disorders?

    P. Kukkle, A. Kaladiyil, T. Geetha, R. Menon, R. Kandadai, V. Goyal, S. Desai, D. Joshi, H. Kumar, P. Wadia, A. Mukherjee, N. Kumar, S. Mehta, S. Chargulla, S. Murugan, H. Shah, V. Paramanandam, M. Chandran, R. Yadav, R. Dhamija, P. Pal, A. Biswas, R. Gupta, R. Borgohain, V. Ramprasad (Bengaluru, India)

    Objective: To elucidate the clinical significance of mutations in the Bassoon (BSN) gene in early-onset Parkinson’s disease (PD). Background: PD involves complex motor deficits beyond…
  • 2025 International Congress

    Effect of Exercise Intervention on Parkinson’s Disease Resting-State fMRI Functional Connectivity

    E. Reimers, C. Bevington, J. Mckenzie, S. Dhaliwal, J. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: Investigate the effects of exercise on resting-state (rs) fMRI functional connectivity (FC) in Parkinson’s Disease (PD). Background: Recent studies have shown strong clinical evidence…
  • 2025 International Congress

    Bone Mineral Density in Early Parkinson’s Disease: Correlations with Disease Severity and Prognosis

    MG. Choi, SY. Jo, JY. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to evaluate the association between bone mineral density (BMD) and disease severity, progression, freezing of gait (FOG), and fracture risk in…
  • 2025 International Congress

    Decreased DTI-ALPS Indices and their Association with Clinical Features in Parkinson’s Disease

    J. Pardo, I. Roura, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, J. Oltra, A. Campabadal, N. Bargalló, MA. Jurado, M. Garolera, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

    Objective: To investigate possible glymphatic dysfunction using diffusion tensor image along the perivascular space (DTI-ALPS) in patients with Parkinson’s disease and their relationship with clinical…
  • 2025 International Congress

    Prospective Tractography-Guided STN DBS Targeting with Optimized vmPFC Connectivity for Apathy in PD a Case Report

    J. de Bruin, K S. Choi, J. Jimenez-Shahed, B. Kopell, H. Mayberg, M. Figee (New York, USA)

    Objective: Prospective tractography-guided DBS targeting of the left STN-vmPFC and primary motor pathway to improve apathy alongside motor symptoms in PD. Background: While STN DBS…
  • 2025 International Congress

    The regulatory variant c.–253C>T of the DNAJC13 gene as a causal factor for Parkinson’s disease in a patient with early-onset

    J. Hoenicka, A. Pascual, P. García-Ruíz, X. Castro-Martínez, R. Repossi, O. de Fabregues, L. Vela-Desojo, M. Mata, I. Torres, JC. Martinez-Castrillo, F. Palau, G. Fernandez (Mexico City, Mexico)

    Objective: This work aims to investigate the role of regulatory regions in Parkinson’s disease (PD) genes, which may help explain part of the missing heritability.…
  • 2025 International Congress

    Interrogating GCase Activity in Human Monocytes Isolated from Parkinson’s Disease Patients Carrying the Asian LRRK2 G2385R and R1628P Variants

    TS. Toh, JW. Hor, SY. Lim, LC. Lit, AN. Khairul Anuar, CY. Lew, YW. Tay, JL. Lim, A. Ahmad-Annuar, K. Zeneviciute, D. Alessi, E. Sammler, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To compare Glucocerebrosidase-1 (GCase) activity in human monocytes of manifesting LRRK2 G2385R, R1628P, and double-variant carriers vs. idiopathic Parkinson’s disease (iPD) and healthy controls…
  • 2025 International Congress

    Genetics of African Americans – Louisiana, Parkinson’s Disease – (GoAAL-PD)

    J. Staisch, S. Breaux, D. Thomas, C. Cevallos, C. Robinson, J. Hines, A. Bonano, L. Davis, J. Henry, N. Crovetto, E. Levenes (New Orleans, USA)

    Objective: Study a cohort of African American patients with PD to understand the genetic underpinnings, phenotypes, barriers to care, and engagement preferences unique to this…
  • 2025 International Congress

    Asymptomatic GBA1 Mutation Carriers Have Increased Cortical Cholinergic Activity

    M. Matarazzo, J. Mckenzie, S. Dhaliwal, Q. Miao, N. Vafai, R. Alcalay, V. Bruno, A. Lehman, J. Quinn, D. Raymond, D. Safarpour, J. Sarna, R. Saunders-Pullman, S. Sirrs, CP. Zabetian, V. Sossi, AJ. Stoessl (Vancouver, Canada)

    Objective: The objective of this study was to assess cholinergic activity changes in patients with Parkinson’s disease carrying GBA1 variants(GBA-PD) and in non-manifesting carriers(GBA-NMC) using…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 436
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley